These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9223178)

  • 1. Mean field analysis of FKBP12 complexes with FK506 and rapamycin: implications for a role of crystallographic water molecules in molecular recognition and specificity.
    Rejto PA; Verkhivker GM
    Proteins; 1997 Jul; 28(3):313-24. PubMed ID: 9223178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus preferred hydration sites in six FKBP12-drug complexes.
    Faerman CH; Karplus PA
    Proteins; 1995 Sep; 23(1):1-11. PubMed ID: 8539241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.
    Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW
    Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
    Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
    Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the differential effects of hydrogen bonding and water release on the binding of FK506 to native and Tyr82-->Phe82 FKBP-12 proteins using free energy simulations.
    Pearlman DA; Connelly PR
    J Mol Biol; 1995 May; 248(3):696-717. PubMed ID: 7538591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).
    Itoh S; Navia MA
    Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressor binding to the immunophilin FKBP59 affects the local structural dynamics of a surface beta-strand: time-resolved fluorescence study.
    Rouviere N; Vincent M; Craescu CT; Gallay J
    Biochemistry; 1997 Jun; 36(24):7339-52. PubMed ID: 9200682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Template-based docking of a prolactin receptor proline-rich motif octapeptide to FKBP12: implications for cytokine receptor signaling.
    Soman KV; Hanks BA; Tien H; Chari MV; O'Neal KD; Morrisett JD
    Protein Sci; 1997 May; 6(5):999-1008. PubMed ID: 9144770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin.
    Wilson KP; Yamashita MM; Sintchak MD; Rotstein SH; Murcko MA; Boger J; Thomson JA; Fitzgibbon MJ; Black JR; Navia MA
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):511-21. PubMed ID: 15299838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan dynamics of the FK506 binding protein: time-resolved fluorescence and simulations.
    Silva ND; Prendergast FG
    Biophys J; 1996 Mar; 70(3):1122-37. PubMed ID: 8785272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution.
    Craescu CT; Rouvière N; Popescu A; Cerpolini E; Lebeau MC; Baulieu EE; Mispelter J
    Biochemistry; 1996 Aug; 35(34):11045-52. PubMed ID: 8780506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of novel, urea-containing FKBP12 inhibitors.
    Dragovich PS; Barker JE; French J; Imbacuan M; Kalish VJ; Kissinger CR; Knighton DR; Lewis CT; Moomaw EW; Parge HE; Pelletier LA; Prins TJ; Showalter RE; Tatlock JH; Tucker KD; Villafranca JE
    J Med Chem; 1996 Apr; 39(9):1872-84. PubMed ID: 8627611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.
    Van Duyne GD; Standaert RF; Karplus PA; Schreiber SL; Clardy J
    J Mol Biol; 1993 Jan; 229(1):105-24. PubMed ID: 7678431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the interaction between FK506 and FKBP12: a mechanism for formation of the calcineurin inhibitory complex.
    Ivery MT; Weiler L
    Bioorg Med Chem; 1997 Feb; 5(2):217-32. PubMed ID: 9061187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex.
    Griffith JP; Kim JL; Kim EE; Sintchak MD; Thomson JA; Fitzgibbon MJ; Fleming MA; Caron PR; Hsiao K; Navia MA
    Cell; 1995 Aug; 82(3):507-22. PubMed ID: 7543369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological identification of a 50 kDa Mr FK506-binding immunophilin as a component of the non-DNA binding, hsp90 and hsp70 containing, heterooligomeric form of the chick oviduct progesterone receptor.
    Renoir JM; Pahl A; Keller U; Baulieu EE
    C R Acad Sci III; 1993 Dec; 316(12):1410-6. PubMed ID: 7522118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand.
    Chakraborty TK; Weber HP; Nicolaou KC
    Chem Biol; 1995 Mar; 2(3):157-61. PubMed ID: 9383417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.
    Luengo JI; Yamashita DS; Dunnington D; Beck AK; Rozamus LW; Yen HK; Bossard MJ; Levy MA; Hand A; Newman-Tarr T
    Chem Biol; 1995 Jul; 2(7):471-81. PubMed ID: 9383449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes.
    DeCenzo MT; Park ST; Jarrett BP; Aldape RA; Futer O; Murcko MA; Livingston DJ
    Protein Eng; 1996 Feb; 9(2):173-80. PubMed ID: 9005438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin.
    Tamura K; Fujimura T; Iwasaki K; Sakuma S; Fujitsu T; Nakamura K; Shimomura K; Kuno T; Tanaka C; Kobayashi M
    Biochem Biophys Res Commun; 1994 Jul; 202(1):437-43. PubMed ID: 7518678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.